Scientists have successfully engineered mice whose brains contain millions of human neurons, representing a significant advancement in the effort to model human brain function and disease in animal subjects. The research, recently published in the journal Nature, was led by Dr. Sergiu Pasca of Stanford University and may open new pathways for understanding neurological disorders and developing treatments.
The team created these "humanized" mice by transplanting brain organoids—miniature, lab-grown replicas of human brain tissue—into genetically modified mice with severely reduced cortical regions. These mice were engineered to lack parts of the brain’s outer layers, the cortex, which in humans is essential for advanced cognitive functions such as decision-making, language, and social behavior. The mice also had compromised immune systems to prevent rejection of human cells.
Once implanted, the human brain organoids expanded substantially from a few hundred thousand cells to as many as four million neurons, integrating with the mouse brain’s blood vessels and thriving within the skull’s fluid environment. Although the human neurons resembled those of a third-trimester human fetus in terms of maturity, they formed functional connections with the surrounding mouse brain tissue and displayed activity during normal mouse behavior.
Behavioral tests indicated that these chimeric mice performed similarly to typical mice in cognitive tasks and showed only subtle differences in movement or memory. Experts unaffiliated with the study noted that despite the large number of human cells, the animals’ overall behavior did not reflect human traits.
The approach addresses longstanding challenges in brain research. Human brains contain approximately 80 billion neurons and intricate neural networks that are difficult to replicate in vitro. Traditional mouse models, while useful, lack many features specific to human brain structure and function. Earlier efforts to study human neurons transplanted into rodents either involved limited integration or encountered challenges from the host's existing neural circuits.
This model has already provided valuable insights into neurological conditions. In the current study, researchers exposed the humanized mice to low-oxygen conditions to simulate perinatal brain injury. The transplanted human neurons were vulnerable to oxygen deprivation, resulting in impairments in motor function that mirror clinical outcomes observed in human infants—an injury typically absent in regular mice. This suggests the model's potential utility for studying human-specific brain injuries and diseases.
Additionally, some transplanted neurons developed into von Economo neurons, a rare type of cell found only in large, socially complex animals, including humans. These neurons are implicated in neurodegenerative diseases like frontotemporal dementia. The presence of von Economo neurons in the chimeric mice allows scientists to examine their role in disease susceptibility and progression.
The research group has been careful to engage with bioethicists and maintain oversight of the animals’ behaviors, noting no signs of enhanced cognitive abilities linked to the human neurons. Still, the creation of animals with substantial human brain tissue raises ethical questions, especially as similar organoid transplantation methods are extended to species with larger brains such as pigs or monkeys.
Experts outside the study underscore the need for updated regulatory frameworks to manage the rapid advances in brain organoid research. Dr. Pasca and colleagues have called for more robust oversight from governments and academic institutions to address the ethical and scientific challenges posed by these novel chimeric models.
This research marks a significant step toward bridging the gap between human brain physiology and animal models, promising new avenues for investigating complex neurological diseases and potential therapies.